BANCR silencing reduced in vivo tumor growth, migration, and EMT via miR-338-3p sponging, which resulted in inhibition of the IGF1R/Raf/MEK/ERK pathway in ESCC cells [79]. Here, BANCR is linked to esophageal squamous cell carcinoma.